Cargando…
The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy
OBJECTIVE: Postmenopausal osteoporosis (PMOP) is a common age-associated disease in the life course. Clinically, Xiaozeng Qianggu Tablets (XQT) have a potent therapeutic effect on the PMOP. However, the bioactive components and the mechanism of XQT underlying the PMOP treatment were unclear and it s...
Autores principales: | Wu, Mingquan, Lai, Huabing, Deng, Qing, Peng, Xi, Shen, Jingshou, Zhou, Xu, Peng, Wei, Zhu, Liyang, Tu, He, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526660/ https://www.ncbi.nlm.nih.gov/pubmed/36193128 http://dx.doi.org/10.1155/2022/3960834 |
Ejemplares similares
-
Qianggu capsule for the treatment of primary osteoporosis: evidence from a Chinese patent medicine
por: Wei, Xu, et al.
Publicado: (2017) -
Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis
por: Huang, Ann Yehong, et al.
Publicado: (2022) -
Effects of bushen qianggu method for primary osteoporosis: A protocol for systematic review and meta-analysis
por: Chen, Guocai, et al.
Publicado: (2020) -
Monotropein: A comprehensive review of biosynthesis, physicochemical properties, pharmacokinetics, and pharmacology
por: Wu, Mingquan, et al.
Publicado: (2023) -
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
por: Hiligsmann, M., et al.
Publicado: (2019)